267 related articles for article (PubMed ID: 10084418)
1. Intravenous azithromycin.
Garey KW; Amsden GW
Ann Pharmacother; 1999 Feb; 33(2):218-28. PubMed ID: 10084418
[TBL] [Abstract][Full Text] [Related]
2. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.
Kohno S; Tateda K; Kadota J; Fujita J; Niki Y; Watanabe A; Nagashima M
J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328
[TBL] [Abstract][Full Text] [Related]
3. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
Yoo BK; Triller DM; Yong CS; Lodise TP
Ann Pharmacother; 2004; 38(7-8):1226-35. PubMed ID: 15187209
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of intravenous azithromycin followed by oral azithromycin for the treatment of acute pelvic inflammatory disease and perihepatitis in Japanese women.
Mikamo H; Iwasaku K; Yamagishi Y; Matsumizu M; Nagashima M
J Infect Chemother; 2014 Jul; 20(7):429-35. PubMed ID: 24787738
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions.
Rapp RP
Ann Pharmacother; 1998; 32(7-8):785-93. PubMed ID: 9681095
[TBL] [Abstract][Full Text] [Related]
6. [Azithromycin and bronchopulmonary infections].
Leophonte P
Pathol Biol (Paris); 1995 Jun; 43(6):534-41. PubMed ID: 8539078
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin and lower respiratory tract infections.
Blasi F; Cazzola M; Tarsia P; Cosentini R; Aliberti S; Santus P; Allegra L
Expert Opin Pharmacother; 2005 Oct; 6(13):2335-51. PubMed ID: 16218893
[TBL] [Abstract][Full Text] [Related]
8. Dirithromycin: a new macrolide.
Wintermeyer SM; Abdel-Rahman SM; Nahata MC
Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
[TBL] [Abstract][Full Text] [Related]
9. Clarithromycin and azithromycin: new macrolide antibiotics.
Piscitelli SC; Danziger LH; Rodvold KA
Clin Pharm; 1992 Feb; 11(2):137-52. PubMed ID: 1312921
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin: the first azalide antibiotic.
Ballow CH; Amsden GW
Ann Pharmacother; 1992 Oct; 26(10):1253-61. PubMed ID: 1330097
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
Zervos M; Mandell LA; Vrooman PS; Andrews CP; McIvor A; Abdulla RH; de Caprariis PJ; Knirsch CA; Amsden GW; Niederman MS; Lode H
Treat Respir Med; 2004; 3(5):329-36. PubMed ID: 15606222
[TBL] [Abstract][Full Text] [Related]
12. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections.
Dunn CJ; Barradell LB
Drugs; 1996 Mar; 51(3):483-505. PubMed ID: 8882383
[TBL] [Abstract][Full Text] [Related]
13. The wobbly status of ketolides: where do we stand?
Georgopapadakou NH
Expert Opin Investig Drugs; 2014 Oct; 23(10):1313-9. PubMed ID: 25154307
[TBL] [Abstract][Full Text] [Related]
14. Azithromycin extended-release (Zmax) for sinusitis and pneumonia.
Obstet Gynecol; 2006 Jan; 107(1):180-2. PubMed ID: 16394059
[No Abstract] [Full Text] [Related]
15. [Azithromycin (sumamed)--basic properties and therapy of community-acquired pneumonia].
Budanov SV
Antibiot Khimioter; 2000; 45(10):28-37. PubMed ID: 11212397
[No Abstract] [Full Text] [Related]
16. SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.
File TM; Rewerska B; Vucinic-Mihailovic V; Gonong JRV; Das AF; Keedy K; Taylor D; Sheets A; Fernandes P; Oldach D; Jamieson BD
Clin Infect Dis; 2016 Oct; 63(8):1007-1016. PubMed ID: 27448679
[TBL] [Abstract][Full Text] [Related]
17. The macrolides: erythromycin, clarithromycin, and azithromycin.
Alvarez-Elcoro S; Enzler MJ
Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
[TBL] [Abstract][Full Text] [Related]
18. An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia.
Todisco T; Dal Farra F; Ciliberti G; Pirina P; Guelfi R; Serra G; Paris R; Mancuso I; Cepparulo M
J Chemother; 2008 Apr; 20(2):225-32. PubMed ID: 18467250
[TBL] [Abstract][Full Text] [Related]
19. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Jorgenson MR; DePestel DD; Carver PL
Ann Pharmacother; 2011 Nov; 45(11):1384-98. PubMed ID: 22009993
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
